(Q35978524)

11 August 2017

Dose finding study of granisetron in patients receiving high-dose cisplatin chemotherapy. The Granisetron Study Group (English)

1 reference

11 August 2017

1 reference

0 references

1 reference

Riviere A

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

69

1 reference

11 August 2017

5

1 reference

11 August 2017

967-971

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.187

11 August 2017

0 references

cites work

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968916

On the receiving end--patient perception of the side-effects of cancer chemotherapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968916

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968916

The role of specific 5-HT3 receptor antagonism in the control of cytostatic drug-induced emesis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968916

The American Academy of Pediatrics comments on the "Baby Doe II" regulations

24 September 2018

1 reference

12 December 2020

Neuropharmacology of Chemotherapy-induced Emesis

1 reference

12 December 2020

Emesis as a Critical Problem in Chemotherapy

1 reference

12 December 2020

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

1 reference

12 December 2020

Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study

1 reference

12 December 2020

Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The Granisetron Study Group

1 reference

12 December 2020

A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group

1 reference

12 December 2020

The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis

1 reference

12 December 2020

A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.187

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

8180032

1 reference